Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53.

[1]  Na Wu,et al.  Antitumor activity of 4-O-(2″-O-acetyl-6″-O-p-coumaroyl-β-D-glucopyranosyl)-p-coumaric acid against lung cancers via mitochondrial-mediated apoptosis. , 2015, Chemico-biological interactions.

[2]  S. Arii,et al.  Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma. , 2014, American journal of surgery.

[3]  K. Rahman,et al.  Effects of Tatariside G Isolated from Fagopyrum tataricum Roots on Apoptosis in Human Cervical Cancer HeLa Cells , 2014, Molecules.

[4]  Ming Xu,et al.  In Vitro and in Vivo Antitumor Activity of Scutebarbatine A on Human Lung Carcinoma A549 Cell Lines , 2014, Molecules.

[5]  K. Al-hosaini,et al.  Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma. , 2014, Chemico-biological interactions.

[6]  C. Zheng,et al.  Anti-allergic rhinitis effect of caffeoylxanthiazonoside isolated from fruits of Xanthium strumarium L. in rodent animals. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  H. Park,et al.  Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  Shu-rong Bai,et al.  Effects of Neurolytic Celiac Plexus Block on Liver Regeneration in Rats with Partial Hepatectomy , 2013, PloS one.

[9]  G. Du,et al.  Scutellaria barbata D. Don extract synergizes the antitumor effects of low dose 5-fluorouracil through induction of apoptosis and metabolism. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  H. Kong,et al.  Downregulation of Mcl-1 through inhibition of translation contributes to benzyl isothiocyanate-induced cell cycle arrest and apoptosis in human leukemia cells , 2013, Cell Death and Disease.

[11]  S. Mohan,et al.  Involvement of NF-κB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells induced by a xanthone compound Pyranocycloartobiloxanthone A. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  C. Zheng,et al.  Cytotoxic phenylpropanoid glycosides from Fagopyrum tataricum (L.) Gaertn. , 2012, Food chemistry.

[13]  L. Qin,et al.  Hepatotoxicity of kaurene glycosides from Xanthium strumarium L. fruits in mice. , 2011, Die Pharmazie.

[14]  R. Hu,et al.  Gambogic acid triggers DNA damage signaling that induces p53/p21(Waf1/CIP1) activation through the ATR-Chk1 pathway. , 2010, Cancer letters.

[15]  Yan-li Liu,et al.  Growth inhibitory and apoptosis inducing by effects of total flavonoids from Lysimachia clethroides Duby in human chronic myeloid leukemia K562 cells. , 2010, Journal of ethnopharmacology.

[16]  Wei Tang,et al.  Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. , 2010, Journal of ethnopharmacology.

[17]  F. Tsai,et al.  Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. , 2010, Biochemical and biophysical research communications.

[18]  N. Moerke,et al.  Fluorescence Polarization (FP) Assays for Monitoring Peptide‐Protein or Nucleic Acid‐Protein Binding , 2009, Current protocols in chemical biology.

[19]  A. Levine,et al.  The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.

[20]  M. Thomas.  Molecular targeted therapy for hepatocellular carcinoma , 2009, Journal of Gastroenterology.

[21]  Kazuyuki Suzuki,et al.  [Adjuvant therapy after treatment of hepatocellular carcinoma]. , 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[22]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[23]  N. Nieto,et al.  [Hepatocyte oxidant stress and alcoholic liver disease]. , 2008, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[24]  K. Wiman,et al.  Reactivation of mutant p53: molecular mechanisms and therapeutic potential , 2007, Oncogene.

[25]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[26]  Tak W. Mak,et al.  Pathways of apoptotic and non-apoptotic death in tumour cells , 2004, Nature Reviews Cancer.

[27]  G. Wahl,et al.  Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation , 2004, The EMBO journal.

[28]  U. Moll,et al.  The MDM2-p53 interaction. , 2003, Molecular cancer research : MCR.

[29]  J. Lunec,et al.  The p53 pathway and its inactivation in neuroblastoma. , 2003, Cancer letters.

[30]  T. Crook,et al.  The p53 pathway in breast cancer , 2002, Breast Cancer Research.

[31]  T. Pawlik,et al.  Epidemiology of hepatocellular carcinoma. , 2015, Surgical oncology clinics of North America.

[32]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[33]  Young Yang,et al.  p53 acetylation enhances Taxol-induced apoptosis in human cancer cells , 2012, Apoptosis.

[34]  Han-Ming Shen,et al.  Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. , 2012, Cancer letters.